Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370485 · ClinicalTrials.gov registry record · Phase 1
A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT02370485 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 23 participants.
The verdict
NCT02370485, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how much of the LY2801653 drug is available in the body when given in 2 different formulations with and without a meal to healthy participants who are not able to have children. In addition, this study will measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study will last about 27 days. Screening is required within 28 days prior to the start of the study.
Interventions
- DRUG LY2801653
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370485
The ClinicalTrials.gov registry entry for NCT02370485 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LY2801653 is the first listed.
NCT02370485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370485 about?
NCT02370485 is a clinical study titled "A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children". The purpose of this study is to evaluate how much of the LY2801653 drug is available in the body when given in 2 different formulations with and without a meal to healthy participants who are not able to have children. In addition, this study will measure how much of the drug gets into the blood str...
What is the current status of trial NCT02370485?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2015-02. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02370485?
The interventions under investigation include: LY2801653 (DRUG).
Who is sponsoring clinical trial NCT02370485?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.